March 26, 2019
Tarveda Therapeutics to Present Nonclinical Data on PEN-221 in Combination with Epigenetic Modulation at the 2019 AACR Annual Meeting
– Data demonstrate how an HDAC inhibitor increases the tumor expression of SSTR2 with synergy of efficacy – WATERTOWN, Mass.–(BUSINESS…